BACKGROUND: Allogeneic skin is currently the best alternative to autologous skin as a temporary treatment for severe burns, but it has several drawbacks. As a potential alternative, we have evaluated GalT-KO swine skin, which lacks expression of the Gal epitope, to investigate the effect of eliminating this epitope on survival of pig-to-baboon skin grafts. METHODS: Two adult baboons that had fully recovered from previous T cell depletion received simultaneous skin grafts from: (i) GalT-KO swine, (ii) Gal-positive swine, (iii) a third-party baboon, and (iv) self (control skin). Recipients were treated with cyclosporin for 12 days and the survival, gross appearance, and histology of the grafts were compared. RESULTS: In both baboons, the GalT-KO skin survived longer than either the Gal-positive swine skin or the allogeneic skin. Early rejection of the Gal-positive skin appeared to be mediated by cytotoxic preformed anti-Gal IgM antibodies, while the rejection of GalT-KO skin appeared to result from cellular mechanisms. CONCLUSIONS: GalT-KO skin may have potential clinical benefits as an alternative to allogeneic skin as a temporary treatment for severe skin injuries.
BACKGROUND: Allogeneic skin is currently the best alternative to autologous skin as a temporary treatment for severe burns, but it has several drawbacks. As a potential alternative, we have evaluated GalT-KO swine skin, which lacks expression of the Gal epitope, to investigate the effect of eliminating this epitope on survival of pig-to-baboon skin grafts. METHODS: Two adult baboons that had fully recovered from previous T cell depletion received simultaneous skin grafts from: (i) GalT-KO swine, (ii) Gal-positive swine, (iii) a third-party baboon, and (iv) self (control skin). Recipients were treated with cyclosporin for 12 days and the survival, gross appearance, and histology of the grafts were compared. RESULTS: In both baboons, the GalT-KO skin survived longer than either the Gal-positive swine skin or the allogeneic skin. Early rejection of the Gal-positive skin appeared to be mediated by cytotoxic preformed anti-Gal IgM antibodies, while the rejection of GalT-KO skin appeared to result from cellular mechanisms. CONCLUSIONS:GalT-KO skin may have potential clinical benefits as an alternative to allogeneic skin as a temporary treatment for severe skin injuries.
Authors: Petr Vodicka; Karel Smetana; Barbora Dvoránková; Teresa Emerick; Yingzhi Z Xu; Jitka Ourednik; Václav Ourednik; Jan Motlík Journal: Ann N Y Acad Sci Date: 2005-05 Impact factor: 5.691
Authors: Banny S Wong; Kazuhiko Yamada; Masayoshi Okumi; Joshua Weiner; Patricia E O'Malley; Yau-Lin Tseng; Frank J M F Dor; David K C Cooper; Susan L Saidman; Adam Griesemer; David H Sachs Journal: Transplantation Date: 2006-08-15 Impact factor: 4.939
Authors: Paul W Holzer; David A Leonard; Kumaran Shanmugarajah; Krysta N Moulton; Zhi Yang Ng; Curtis L Cetrulo; David H Sachs Journal: J Burn Care Res Date: 2017 Jan/Feb Impact factor: 1.845
Authors: Alexander Albritton; David A Leonard; Angelo Leto Barone; Josh Keegan; Christopher Mallard; David H Sachs; Josef M Kurtz; Curtis L Cetrulo Journal: Transplantation Date: 2014-06-27 Impact factor: 4.939
Authors: David K C Cooper; Vikas Satyananda; Burcin Ekser; Dirk J van der Windt; Hidetaka Hara; Mohamed B Ezzelarab; Henk-Jan Schuurman Journal: Xenotransplantation Date: 2014-09-01 Impact factor: 3.907
Authors: Melissa Mastroianni; Zhi Yang Ng; Ritu Goyal; Christopher Mallard; Evan A Farkash; David A Leonard; Alexander Albritton; Kumaran Shanmugarajah; Josef M Kurtz; David H Sachs; Lauren K Macri; Joachim Kohn; Curtis L Cetrulo Journal: J Burn Care Res Date: 2018-04-20 Impact factor: 1.845